Prognostic value of minimal residual disease measured by fusion-gene transcript in infants with KMT2A-rearranged acute lymphoblastic leukaemia treated according to the MLL-Baby protocol.
Br J Haematol
; 193(6): 1151-1156, 2021 06.
Article
in En
| MEDLINE
| ID: mdl-33583020
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Oncogene Proteins, Fusion
/
Histone-Lysine N-Methyltransferase
/
Myeloid-Lymphoid Leukemia Protein
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Female
/
Humans
/
Infant
/
Male
/
Newborn
Language:
En
Journal:
Br J Haematol
Year:
2021
Type:
Article